TOT BIOPHARM INTERNATIONAL COMPANY LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.89 HKD | +1.07% |
|
+8.62% | -4.06% |
| Mar. 15 | TOT BIOPHARM International Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | TOT Biopharm's Loss Narrows in January-September Period | MT |
Evolution of the average Target Price on TOT BIOPHARM International Company Limited
Price target over the last 5 years
History of analyst recommendation changes
1bedbda.Zpw5VmpERhBqN2INfpJCt0QeVxUEitQUq8ybczbS7Sk.Mq1NFSE2FD04exhnOchywzVfA3tp2Z1z6vryRlSLjEQKyHhuCw8iZUd9Wg~a75fd9ae2fc6efe30dfb21c393e64db9
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.725
CNY
Average target price
3.486
CNY
Spread / Average Target
+102.04%
High Price Target
3.486
CNY
Spread / Highest target
+102.04%
Low Price Target
3.486
CNY
Spread / Lowest Target
+102.04%
Consensus detail
Consensus revision (last 18 months)
Annual profits - Rate of surprise
- Stock Market
- Equities
- 1875 Stock
- Consensus TOT BIOPHARM International Company Limited